4-((4-Methoxyphenyl)amino)-2,2-dimethyl-3,4-dihydro-2H-benzo[g]chromene-5,10-dione

ID: ALA3114589

PubChem CID: 76332317

Max Phase: Preclinical

Molecular Formula: C22H21NO4

Molecular Weight: 363.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(NC2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)cc1

Standard InChI:  InChI=1S/C22H21NO4/c1-22(2)12-17(23-13-8-10-14(26-3)11-9-13)18-19(24)15-6-4-5-7-16(15)20(25)21(18)27-22/h4-11,17,23H,12H2,1-3H3

Standard InChI Key:  SGUSEXOKZCOCFX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   11.3421  -19.0685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1663  -19.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7540  -18.3547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0453  -19.0799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0441  -19.9063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7582  -20.3188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7564  -18.6675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4710  -19.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4745  -19.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1929  -20.3193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1861  -18.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1815  -17.8308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1951  -21.1435    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9091  -19.0703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9102  -19.8996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6249  -20.3110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3431  -19.8978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6228  -18.6525    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6249  -21.1352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3385  -21.5473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3352  -22.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0481  -22.7812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7628  -22.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7603  -21.5408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0468  -21.1325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4770  -22.7803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4780  -23.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 15  1  0
 14 11  1  0
 11 12  2  0
 10 13  2  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  1  0
 17  1  1  0
  1 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
M  END

Associated Targets(Human)

PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MX1 (889 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

V79 (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.41Molecular Weight (Monoisotopic): 363.1471AlogP: 4.01#Rotatable Bonds: 3
Polar Surface Area: 64.63Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.05CX LogP: 2.66CX LogD: 2.65
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.89Np Likeness Score: 0.40

References

1. da Cruz EH, Hussene CM, Dias GG, Diogo EB, de Melo IM, Rodrigues BL, da Silva MG, Valença WO, Camara CA, de Oliveira RN, de Paiva YG, Goulart MO, Cavalcanti BC, Pessoa C, da Silva Júnior EN..  (2014)  1,2,3-triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones.,  22  (5): [PMID:24530030] [10.1016/j.bmc.2014.01.033]
2. da Silva Júnior EN, Jardim GAM, Jacob C, Dhawa U, Ackermann L, de Castro SL..  (2019)  Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones.,  179  [PMID:31306817] [10.1016/j.ejmech.2019.06.056]

Source